1. Home
  2. INTS vs BGI Comparison

INTS vs BGI Comparison

Compare INTS & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$0.40

Market Cap

24.0M

Sector

Health Care

ML Signal

HOLD

Logo Birks Group Inc.

BGI

Birks Group Inc.

HOLD

Current Price

$0.92

Market Cap

22.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTS
BGI
Founded
2012
1879
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.0M
22.7M
IPO Year
2023
2005

Fundamental Metrics

Financial Performance
Metric
INTS
BGI
Price
$0.40
$0.92
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$4.33
N/A
AVG Volume (30 Days)
2.5M
37.7K
Earning Date
11-06-2025
12-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$136,846,182.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.45
52 Week Low
$0.19
$0.56
52 Week High
$3.17
$2.03

Technical Indicators

Market Signals
Indicator
INTS
BGI
Relative Strength Index (RSI) 46.75 37.07
Support Level $0.39 $1.00
Resistance Level $0.42 $0.93
Average True Range (ATR) 0.03 0.03
MACD -0.00 -0.00
Stochastic Oscillator 42.15 18.41

Price Performance

Historical Comparison
INTS
BGI

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About BGI Birks Group Inc.

Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.

Share on Social Networks: